Company name |
Beschreibung |
|---|---|
| 20/20 Genesystems |
Our patented technology simultaneously analyzes multiple biomarkers in tumors in order to predict patient response to one or more targeted therapies. |
| 2009 NanoCarrier Co., Ltd |
NanoCarrier's core technology, micellar nanoparticles technology, was proposed and has been researched by Professor Kazunori Kataoka of University of Tokyo, Professor Teruo Okano of Tokyo Women's Medical University and Associate professor Masayuki Yokoyama of the Jikei University. |
| 3rd Millenium |
The award winning Array Repository and Data Analysis System (ARDAS™) provides a complete and fully integrated solution to microarray data acquisition, management, and analysis. |
| 454 Sequencing |
Rapid DNA Sequencing and Screening Analysis for Whole Genomes, mRNA, PCR, & cDNA. Polymorphism Analysis & Sage™ Research for Pharmacogenomics, Comparative Genomics, & Genotyping. |
| 4SC - Developing Pharmaceutical Success |
4SC is a drug discovery and development company, that provides an innovative technology platform by combining chemistry, biology and virtual High Throughput Sreening in order to reduce time and cost of the drug discovery process. |
| 7TM PHARMA |
At 7TM Pharma we focus on developing our pipeline of clinical assets forward with a primary therapeutic focus in obesity, related metabolic diseases and gastrointestinal diseases. These are areas with obvious unmet medicinal needs. |
| Abbott Molecular Inc. |
Molecular diagnostics and analysis of DNA, RNA, and proteins at molecular level |
| ABC Labs |
Contract Research Organization delivering product development and analytical testing services |
| Abcam plc. |
Antibodies & Reagents, find any antibody. |
| Abgent Antibodies and Peptides |
Genome wide antibody coverage with an emphasis on autophagy, stem cells, and neurodegenerative diseases |
| Able Software |
Able Software 3D DOCTOR R2V |
| AbSorber |
AbSorber AB is a biotech company focused on developing products that increase the probability of transplantation success. XM-ONE®, the first AbSorber product on the market, is a CE-marked and FDA registered transplantation crossmatch test kit. |
| ACADIA |
Biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders |
| Accelrys |
Based on its analysis of the integrated insilico drug discovery solutions market, Frost & Sullivan recognized Accelrys, Inc., with the 2010 North America Frost & Sullivan Award for New Product Innovation of the Year. |
| ACE BioSciences A/S |
Discovers and develops novel products to fight serious life threatening diseases |
| ActivX Biosciences, Inc. |
Discovers and develops small molecule drugs for major unmet medical needs. Identifies target and off-target activities of drug candidates in the protein kinase and protease families with an initial focus on the areas of hematology, oncology, metabolic and inflammatory diseases. |
| Advanced ChemTech |
Peptide-based pharmaceutical research and manufacturing, and innovative medical device design and development |
| Advion BioSciences |
Bioanalytical contract services to the pharmaceutical industry |
| Affibody |
Biopharmaceuticals based on proprietary technology platforms: Affibody® molecules and Albumod™. |
| Affinium Pharmaceuticals |
Germinated from assets acquired in 2003 from GSK, Affinium's antibacterial programs now include a broad base of intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors, genes, proteins, assays, crystal structures and combin |